Treg Modulation With CD28 and IL-6 Receptor Antagonists
Conditions: Living-Donor Kidney Transplant; Kidney Transplant Recipients Interventions: Biological: lulizumab pegol; Biological: antithymocyte globulin (rabbit); Drug: methylprednisolone; Biological: tocilizumab; Drug: Prednisone; Drug: everolimus; Biological: belatacept; Drug: mycophenolate mofetil; Drug: mycophenolic acid Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Bristol-Myers Squibb; Clinical Trials in Organ Transplantation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actemra | Allergy | Allergy & Immunology | Infectious Diseases | Methylprednisolone | Prednisone | Research | Transplant Surgery | Transplants | Urology & Nephrology